Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Dolby Laboratories, Inc.DLB · Entity 2518 | Director | April 01, 2026 | April 03, 2026 |
| Xometry, Inc.XMTR · Entity 1915 | Director | August 19, 2026 | August 21, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Dolby Laboratories, Inc.
Report date April 01, 2026 · Filed April 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 12,541 |
Reported balance
After 2026-04-01 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-04-01 · Sale · Disposed 1,000 · Balance 12,541 F1: Shares held following the reported transaction included 3,908 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares held following the reported transaction included 3,908 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest.
Xometry, Inc.
Report date August 19, 2026 · Filed August 21, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 15,136 |
Ending reported balance
After 2026-08-19 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2026-08-19 · Exercise / conversion · Acquired 5,000 · Balance 20,136 F1: Represents shares sold in a transaction that was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date. Row 2 · 2026-08-19 · Sale · Disposed 2,540 · Balance 17,596 F1: Represents shares sold in a transaction that was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date. F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.155 to $84.125, inclusive. The reporting person undertakes to provide to Xometry, Inc., any security holder of Xometry, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price in the ranges set forth in footnotes (2), (3) and (4) to this Form 4. Row 3 · 2026-08-19 · Sale · Disposed 1,692 · Balance 15,904 F1: Represents shares sold in a transaction that was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date. F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.17 to $85.17, inclusive. Row 4 · 2026-08-19 · Sale · Disposed 768 · Balance 15,136 F1: Represents shares sold in a transaction that was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date. F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.22 to $86.07, inclusive. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $12.32 · Expires 2031-02-24 | Direct | 41,650 |
Reported balance
After 2026-08-19 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-08-19 · Exercise / conversion · Acquired 5,000 · Balance 41,650 F1: Represents shares sold in a transaction that was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date. F5: Fully vested. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares sold in a transaction that was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.155 to $84.125, inclusive. The reporting person undertakes to provide to Xometry, Inc., any security holder of Xometry, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price in the ranges set forth in footnotes (2), (3) and (4) to this Form 4.
F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.17 to $85.17, inclusive.
F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.22 to $86.07, inclusive.
F5: Fully vested.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
McAfee Corp.
Report date March 01, 2022 · Filed March 03, 2022
Section 16 reporting ended · disclosed 2022-03-03. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2022-03-01 transaction · row 1
1 source rowRow 1 · 2022-03-01 · Disposition to issuer · Disposed 6,878 · Balance 0 F1: Includes restricted stock units ("RSUs") that represent the Reporting Person's right to receive shares of Class A common stock of the Issuer. The RSUs were cancelled pursuant to that certain Merger Agreement, dated November 5, 2021, between the Issuer, Condor BidCo, Inc. and Condor Merger Sub, Inc., in exchange for a cash payment of $26.00 per share. |
Filing footnotes · ownership attribution and instrument terms
F1: Includes restricted stock units ("RSUs") that represent the Reporting Person's right to receive shares of Class A common stock of the Issuer. The RSUs were cancelled pursuant to that certain Merger Agreement, dated November 5, 2021, between the Issuer, Condor BidCo, Inc. and Condor Merger Sub, Inc., in exchange for a cash payment of $26.00 per share.
Science 37 Holdings, Inc.
Report date March 12, 2024 · Filed March 12, 2024
Section 16 reporting ended · disclosed 2024-03-12. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2024-03-12 transaction · row 1
1 source rowRow 1 · 2024-03-12 · Other · Disposed 2,050 · Balance 0 F1: This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the "Merger Agreement"), dated as of January 28, 2024, among the Issuer, eMed, LLC, a Delaware limited liability company ("Parent"), and Marlin Merger Sub Corporation, a Delaware corporation and a wholly owned subsidiary of Parent ("Merger Sub"), pursuant to which Merger Sub completed a tender offer for shares of common stock of the Issuer ("Issuer Common Stock") at a purchase price of $5.75 per share, without interest and subject to applicable withholding taxes (the "Offer Price"). After completion of the tender offer, Merger Sub merged with and into the Issuer, effective as of March 12, 2024 (such date and time of such merger, the "Effective Time"). These shares of Issuer Common Stock were tendered for purchase pursuant to the tender offer. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2024-03-12 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2024-03-12 · Disposition to issuer · Disposed 24,742 · Balance 0 F2: Represents restricted stock units ("RSUs") granted to the Reporting Person. Each RSU represented a contingent right to receive one share of Issuer Common Stock upon vesting of the RSU. F3: Pursuant to the Merger Agreement, at the Effective Time, each RSU that was outstanding as of immediately prior to the Effective Time was cancelled and converted into the right to receive a cash payment (without interest and subject to any applicable tax withholding) equal to (A) the Offer Price, multiplied by (B) the number of shares of Issuer Common Stock subject to such RSU. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $201.00 | Direct | 0 |
Reported balance
After 2024-03-12 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2024-03-12 · Disposition to issuer · Disposed 1,378 · Balance 0 F4: Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of Issuer Common Stock that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was equal to or greater than the Offer Price was cancelled with no consideration payable in respect thereof. |
Filing footnotes · ownership attribution and instrument terms
F1: This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the "Merger Agreement"), dated as of January 28, 2024, among the Issuer, eMed, LLC, a Delaware limited liability company ("Parent"), and Marlin Merger Sub Corporation, a Delaware corporation and a wholly owned subsidiary of Parent ("Merger Sub"), pursuant to which Merger Sub completed a tender offer for shares of common stock of the Issuer ("Issuer Common Stock") at a purchase price of $5.75 per share, without interest and subject to applicable withholding taxes (the "Offer Price"). After completion of the tender offer, Merger Sub merged with and into the Issuer, effective as of March 12, 2024 (such date and time of such merger, the "Effective Time"). These shares of Issuer Common Stock were tendered for purchase pursuant to the tender offer.
F2: Represents restricted stock units ("RSUs") granted to the Reporting Person. Each RSU represented a contingent right to receive one share of Issuer Common Stock upon vesting of the RSU.
F3: Pursuant to the Merger Agreement, at the Effective Time, each RSU that was outstanding as of immediately prior to the Effective Time was cancelled and converted into the right to receive a cash payment (without interest and subject to any applicable tax withholding) equal to (A) the Offer Price, multiplied by (B) the number of shares of Issuer Common Stock subject to such RSU.
F4: Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of Issuer Common Stock that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was equal to or greater than the Offer Price was cancelled with no consideration payable in respect thereof.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 19, 2026 Filed Aug 21, 2026 20:28 UTC | Xometry, Inc. XMTR · Entity 1915 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $12.32 | $0.00 |
DisclosureSEC source: 0001847014-26-000005 · primarydocument.xml · derivative · entry 5 Rollins Emily · CIK 0001847014 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 41,650 Underlying: Class A Common Stock · 5,000 shares Expires 2031-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents shares sold in a transaction that was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date. F5 · derivative.exercise_date: Fully vested. Read SEC document |
| August 19, 2026 Filed Aug 21, 2026 20:28 UTC | Xometry, Inc. XMTR · Entity 1915 | SaleClass A Common Stock | 768 | $85.47 | $65,638.35 |
DisclosureSEC source: 0001847014-26-000005 · primarydocument.xml · nonDerivative · entry 4 Rollins Emily · CIK 0001847014 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,136 F1 · kind: Represents shares sold in a transaction that was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.22 to $86.07, inclusive. Read SEC document |
| August 19, 2026 Filed Aug 21, 2026 20:28 UTC | Xometry, Inc. XMTR · Entity 1915 | SaleClass A Common Stock | 1,692 | $84.83 | $143,527.28 |
DisclosureSEC source: 0001847014-26-000005 · primarydocument.xml · nonDerivative · entry 3 Rollins Emily · CIK 0001847014 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,904 F1 · kind: Represents shares sold in a transaction that was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.17 to $85.17, inclusive. Read SEC document |
| August 19, 2026 Filed Aug 21, 2026 20:28 UTC | Xometry, Inc. XMTR · Entity 1915 | SaleClass A Common Stock | 2,540 | $83.61 | $212,362.54 |
DisclosureSEC source: 0001847014-26-000005 · primarydocument.xml · nonDerivative · entry 2 Rollins Emily · CIK 0001847014 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 17,596 F1 · kind: Represents shares sold in a transaction that was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.155 to $84.125, inclusive. The reporting person undertakes to provide to Xometry, Inc., any security holder of Xometry, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price in the ranges set forth in footnotes (2), (3) and (4) to this Form 4. Read SEC document |
| August 19, 2026 Filed Aug 21, 2026 20:28 UTC | Xometry, Inc. XMTR · Entity 1915 | Exercise / conversionClass A Common Stock | 5,000 | $12.32 | $61,600.00 |
DisclosureSEC source: 0001847014-26-000005 · primarydocument.xml · nonDerivative · entry 1 Rollins Emily · CIK 0001847014 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 20,136 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents shares sold in a transaction that was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date. Read SEC document |
| April 01, 2026 Filed Apr 3, 2026 21:11 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 1,000 | $60.08 | $60,080.00 |
DisclosureSEC source: 0001193125-26-142335 · ownership.xml · nonDerivative · entry 1 Rollins Emily · CIK 0001847014 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 12,541 F1 · balance_after: Shares held following the reported transaction included 3,908 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| April 01, 2026 Filed Apr 3, 2026 19:59 UTC | Xometry, Inc. XMTR · Entity 1915 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,000 | $0.00 Strike: $12.32 | $0.00 |
DisclosureSEC source: 0001847014-26-000004 · primarydocument.xml · derivative · entry 3 Rollins Emily · CIK 0001847014 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 36,650 Underlying: Class A Common Stock · 1,000 shares Expires 2031-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents shares sold in a transaction that was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date. F3 · derivative.exercise_date: Fully vested. Read SEC document |
| April 01, 2026 Filed Apr 3, 2026 19:59 UTC | Xometry, Inc. XMTR · Entity 1915 | SaleClass A Common Stock | 1,000 | $42.02 | $42,017.40 |
DisclosureSEC source: 0001847014-26-000004 · primarydocument.xml · nonDerivative · entry 2 Rollins Emily · CIK 0001847014 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,136 F1 · kind: Represents shares sold in a transaction that was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.60 to $42.42, inclusive. The reporting person undertakes to provide to Xometry, Inc., any security holder of Xometry, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this price range. Read SEC document |
| April 01, 2026 Filed Apr 3, 2026 19:59 UTC | Xometry, Inc. XMTR · Entity 1915 | Exercise / conversionClass A Common Stock | 1,000 | $12.32 | $12,320.00 |
DisclosureSEC source: 0001847014-26-000004 · primarydocument.xml · nonDerivative · entry 1 Rollins Emily · CIK 0001847014 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 16,136 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents shares sold in a transaction that was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date. Read SEC document |
| March 10, 2026 Filed Mar 12, 2026 20:37 UTC | Xometry, Inc. XMTR · Entity 1915 | GrantClass A Common Stock | 3,681 | $0.00 | $0.00 |
DisclosureSEC source: 0001847014-26-000003 · primarydocument.xml · nonDerivative · entry 1 Rollins Emily · CIK 0001847014 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,136 F1 · shares: Represents a restricted stock unit ("RSU") grant. All of the shares underlying the RSUs will vest on January 1, 2027, subject to the Reporting Person's continuous service. F2 · price: Each RSU represents a contingent right to receive one share of the Class A Common Stock of the Issuer. Read SEC document |
| February 03, 2026 Filed Feb 6, 2026 00:47 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GrantClass A Common Stock | 3,908 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-039907 · ownership.xml · nonDerivative · entry 1 Rollins Emily · CIK 0001847014 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,541 F1 · acquired: Award represents a total of 3,908 restricted stock units granted under the terms of the Issuer's 2020 Stock Plan. Each unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon vesting, which will occur on the earlier of (i) the first anniversary of the date of grant or (ii) the date immediately preceding the date of Issuer's 2027 annual meeting of stockholders, provided that, in either case, the Reporting Person continues to serve as a member of the Issuer's board of directors on such date. F2 · balance_after: Shares held following the reported transactions include 3,908 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 21:44 UTC | Xometry, Inc. XMTR · Entity 1915 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,000 | $0.00 Strike: $12.32 | $0.00 |
DisclosureSEC source: 0001847014-26-000002 · primarydocument.xml · derivative · entry 4 Rollins Emily · CIK 0001847014 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 350 Underlying: Class A Common Stock · 1,000 shares Expires 2031-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date. F4 · derivative.exercise_date: Fully vested. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 21:44 UTC | Xometry, Inc. XMTR · Entity 1915 | SaleClass A Common Stock | 725 | $62.23 | $45,116.03 |
DisclosureSEC source: 0001847014-26-000002 · primarydocument.xml · nonDerivative · entry 3 Rollins Emily · CIK 0001847014 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,455 F1 · kind: The transaction reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.61 to $62.59, inclusive. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 21:44 UTC | Xometry, Inc. XMTR · Entity 1915 | SaleClass A Common Stock | 275 | $60.90 | $16,746.13 |
DisclosureSEC source: 0001847014-26-000002 · primarydocument.xml · nonDerivative · entry 2 Rollins Emily · CIK 0001847014 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 12,180 F1 · kind: The transaction reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.24 to $61.235, inclusive. The reporting person undertakes to provide to Xometry, Inc., any security holder of Xometry, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price in the ranges set forth in footnotes (2) and (3) to this Form 4. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 21:44 UTC | Xometry, Inc. XMTR · Entity 1915 | Exercise / conversionClass A Common Stock | 1,000 | $12.32 | $12,320.00 |
DisclosureSEC source: 0001847014-26-000002 · primarydocument.xml · nonDerivative · entry 1 Rollins Emily · CIK 0001847014 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 12,455 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date. Read SEC document |
| November 10, 2025 Filed Nov 12, 2025 21:38 UTC | Xometry, Inc. XMTR · Entity 1915 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,000 | $0.00 Strike: $12.32 | $0.00 |
DisclosureSEC source: 0001847014-25-000003 · primarydocument.xml · derivative · entry 5 Rollins Emily · CIK 0001847014 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,350 Underlying: Class A Common Stock · 1,000 shares Expires 2031-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date. F5 · derivative.exercise_date: Fully vested. Read SEC document |
| November 10, 2025 Filed Nov 12, 2025 21:38 UTC | Xometry, Inc. XMTR · Entity 1915 | SaleClass A Common Stock | 708 | $68.53 | $48,520.37 |
DisclosureSEC source: 0001847014-25-000003 · primarydocument.xml · nonDerivative · entry 4 Rollins Emily · CIK 0001847014 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,455 F1 · kind: The transaction reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $68.185 to $68.87, inclusive. Read SEC document |
| November 10, 2025 Filed Nov 12, 2025 21:38 UTC | Xometry, Inc. XMTR · Entity 1915 | SaleClass A Common Stock | 186 | $67.16 | $12,491.93 |
DisclosureSEC source: 0001847014-25-000003 · primarydocument.xml · nonDerivative · entry 3 Rollins Emily · CIK 0001847014 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 12,163 F1 · kind: The transaction reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.07 to $67.26, inclusive. Read SEC document |
| November 10, 2025 Filed Nov 12, 2025 21:38 UTC | Xometry, Inc. XMTR · Entity 1915 | SaleClass A Common Stock | 106 | $66.16 | $7,013.19 |
DisclosureSEC source: 0001847014-25-000003 · primarydocument.xml · nonDerivative · entry 2 Rollins Emily · CIK 0001847014 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 12,349 F1 · kind: The transaction reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.89 to $66.715, inclusive. The reporting person undertakes to provide to Xometry, Inc., any security holder of Xometry, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price in the ranges set forth in footnotes (2), (3) and (4) to this Form 4. Read SEC document |
| November 10, 2025 Filed Nov 12, 2025 21:38 UTC | Xometry, Inc. XMTR · Entity 1915 | Exercise / conversionClass A Common Stock | 1,000 | $12.32 | $12,320.00 |
DisclosureSEC source: 0001847014-25-000003 · primarydocument.xml · nonDerivative · entry 1 Rollins Emily · CIK 0001847014 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 12,455 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date. Read SEC document |
| August 11, 2025 Filed Aug 12, 2025 20:26 UTC | Xometry, Inc. XMTR · Entity 1915 | Exercise / conversionStock Option (Right to Buy) · Derivative | 350 | $0.00 Strike: $12.32 | $0.00 |
DisclosureSEC source: 0001562180-25-005724 · primarydocument.xml · derivative · entry 2 Rollins Emily · CIK 0001847014 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 350 Underlying: Class A Common Stock · 350 shares Expires 2031-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Fully vested. Read SEC document |
| August 11, 2025 Filed Aug 12, 2025 20:26 UTC | Xometry, Inc. XMTR · Entity 1915 | Exercise / conversionClass A Common Stock | 350 | $12.32 | $4,312.00 |
DisclosureSEC source: 0001562180-25-005724 · primarydocument.xml · nonDerivative · entry 1 Rollins Emily · CIK 0001847014 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,455 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 09, 2025 Filed May 9, 2025 21:04 UTC | Xometry, Inc. XMTR · Entity 1915 | Exercise / conversionStock Options (Right to buy) · Derivative | 5,000 | $0.00 Strike: $12.32 | $0.00 |
DisclosureSEC source: 0001562180-25-003725 · primarydocument.xml · derivative · entry 4 Rollins Emily · CIK 0001847014 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,000 Underlying: Class A Common Stock · 5,000 shares Expires 2031-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Fully vested. Read SEC document |
| May 09, 2025 Filed May 9, 2025 21:04 UTC | Xometry, Inc. XMTR · Entity 1915 | SaleClass A Common Stock | 5,041 | $30.69 | $154,724.93 |
DisclosureSEC source: 0001562180-25-003725 · primarydocument.xml · nonDerivative · entry 3 Rollins Emily · CIK 0001847014 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,105 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.69 to $30.76, inclusive. Read SEC document |
| May 09, 2025 Filed May 9, 2025 21:04 UTC | Xometry, Inc. XMTR · Entity 1915 | SaleClass A Common Stock | 5,000 | $30.71 | $153,553.00 |
DisclosureSEC source: 0001562180-25-003725 · primarydocument.xml · nonDerivative · entry 2 Rollins Emily · CIK 0001847014 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,146 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.71 to $30.74, inclusive. The reporting person undertakes to provide to Xometry, Inc., any security holder of Xometry, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price in the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| May 09, 2025 Filed May 9, 2025 21:04 UTC | Xometry, Inc. XMTR · Entity 1915 | Exercise / conversionClass A Common Stock | 5,000 | $12.32 | $61,600.00 |
DisclosureSEC source: 0001562180-25-003725 · primarydocument.xml · nonDerivative · entry 1 Rollins Emily · CIK 0001847014 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,146 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 07, 2025 Filed Apr 8, 2025 20:35 UTC | Xometry, Inc. XMTR · Entity 1915 | SaleClass A Common Stock | 555 | $21.28 | $11,809.57 |
DisclosureSEC source: 0001562180-25-003071 · primarydocument.xml · nonDerivative · entry 3 Rollins Emily · CIK 0001847014 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 16,146 F1 · kind: The transaction reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.125 to $21.515, inclusive. Read SEC document |
| April 07, 2025 Filed Apr 8, 2025 20:35 UTC | Xometry, Inc. XMTR · Entity 1915 | SaleClass A Common Stock | 1,211 | $20.59 | $24,940.18 |
DisclosureSEC source: 0001562180-25-003071 · primarydocument.xml · nonDerivative · entry 2 Rollins Emily · CIK 0001847014 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 16,701 F1 · kind: The transaction reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.10 to $21.085, inclusive. Read SEC document |
| April 07, 2025 Filed Apr 8, 2025 20:35 UTC | Xometry, Inc. XMTR · Entity 1915 | SaleClass A Common Stock | 234 | $19.52 | $4,568.52 |
DisclosureSEC source: 0001562180-25-003071 · primarydocument.xml · nonDerivative · entry 1 Rollins Emily · CIK 0001847014 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 17,912 F1 · kind: The transaction reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.89 to $19.555, inclusive. The reporting person undertakes to provide to Xometry, Inc., any security holder of Xometry, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price in the ranges set forth in footnotes (2), (3) and (4) to this Form 4. Read SEC document |
| March 11, 2025 Filed Mar 13, 2025 20:24 UTC | Xometry, Inc. XMTR · Entity 1915 | GrantClass A Common Stock | 5,689 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-002359 · primarydocument.xml · nonDerivative · entry 1 Rollins Emily · CIK 0001847014 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,146 F1 · shares: Represents a restricted stock unit ("RSU") grant. All of the shares underlying the RSUs will vest on January 1, 2026, subject to the Reporting Person's continuous service. F2 · price: Each RSU represents a contingent right to receive one share of the Class A Common Stock of the Issuer. Read SEC document |
| February 04, 2025 Filed Feb 7, 2025 00:28 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GrantClass A Common Stock | 3,140 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-015653 · ownership.xml · nonDerivative · entry 1 Rollins Emily · CIK 0001847014 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,633 F1 · acquired: Award represents a total of 3,140 restricted stock units granted under the terms of the Issuer's 2020 Stock Plan. Each unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon vesting, which will occur on the earlier of (i) the first anniversary of the date of grant or (ii) the date immediately preceding the date of Issuer's 2026 annual meeting of stockholders, provided that, in either case, the Reporting Person continues to serve as a member of the Issuer's board of directors on such date. F2 · balance_after: Shares held following the reported transactions include 3,140 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| January 30, 2025 Filed Feb 4, 2025 01:27 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 1,000 | $84.90 | $84,900.00 |
DisclosureSEC source: 0000950170-25-012639 · ownership.xml · nonDerivative · entry 1 Rollins Emily · CIK 0001847014 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 6,493 F1 · balance_after: Shares held following the reported transaction included 2,952 shares of Class A common stock underlying restricted stock units, which vest on the date of this Form 4. Read SEC document |
| November 07, 2024 Filed Nov 12, 2024 21:23 UTC | Xometry, Inc. XMTR · Entity 1915 | SaleClass A Common Stock | 624 | $30.11 | $18,788.33 |
DisclosureSEC source: 0001562180-24-007644 · primarydocument.xml · nonDerivative · entry 2 Rollins Emily · CIK 0001847014 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 12,457 F1 · kind: Represents shares sold in a transaction that was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.97 to $30.275, inclusive. Read SEC document |
| November 07, 2024 Filed Nov 12, 2024 21:23 UTC | Xometry, Inc. XMTR · Entity 1915 | SaleClass A Common Stock | 3,105 | $29.36 | $91,178.01 |
DisclosureSEC source: 0001562180-24-007644 · primarydocument.xml · nonDerivative · entry 1 Rollins Emily · CIK 0001847014 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 13,081 F1 · kind: Represents shares sold in a transaction that was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.94 to $29.795, inclusive. The reporting person undertakes to provide to Xometry, Inc., any security holder of Xometry, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price in the ranges set forth in footnotes (2) and (3) to this Form 4. Read SEC document |
| March 12, 2024 Filed Mar 12, 2024 10:06 UTC | Science 37 Holdings, Inc. SNCE · Entity 15235 | Disposition to issuerStock Option · Derivative | 1,378 | Not disclosed Strike: $201.00 | Not disclosed |
DisclosureSEC source: 0001819113-24-000017 · wk-form4_1710252389.xml · derivative · entry 3 Rollins Emily · CIK 0001847014 · Former Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,378 shares Expires not disclosed F4 · price: Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of Issuer Common Stock that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was equal to or greater than the Offer Price was cancelled with no consideration payable in respect thereof. F4 · derivative.exercise_date: Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of Issuer Common Stock that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was equal to or greater than the Offer Price was cancelled with no consideration payable in respect thereof. F4 · derivative.expiration_date: Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of Issuer Common Stock that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was equal to or greater than the Offer Price was cancelled with no consideration payable in respect thereof. Read SEC document |
| March 12, 2024 Filed Mar 12, 2024 10:06 UTC | Science 37 Holdings, Inc. SNCE · Entity 15235 | Disposition to issuerRestricted Stock Units · Derivative | 24,742 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001819113-24-000017 · wk-form4_1710252389.xml · derivative · entry 2 Rollins Emily · CIK 0001847014 · Former Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 24,742 shares Expires not disclosed F2 · derivative.exercise_price: Represents restricted stock units ("RSUs") granted to the Reporting Person. Each RSU represented a contingent right to receive one share of Issuer Common Stock upon vesting of the RSU. F3 · derivative.exercise_price: Pursuant to the Merger Agreement, at the Effective Time, each RSU that was outstanding as of immediately prior to the Effective Time was cancelled and converted into the right to receive a cash payment (without interest and subject to any applicable tax withholding) equal to (A) the Offer Price, multiplied by (B) the number of shares of Issuer Common Stock subject to such RSU. F2 · price: Represents restricted stock units ("RSUs") granted to the Reporting Person. Each RSU represented a contingent right to receive one share of Issuer Common Stock upon vesting of the RSU. F3 · price: Pursuant to the Merger Agreement, at the Effective Time, each RSU that was outstanding as of immediately prior to the Effective Time was cancelled and converted into the right to receive a cash payment (without interest and subject to any applicable tax withholding) equal to (A) the Offer Price, multiplied by (B) the number of shares of Issuer Common Stock subject to such RSU. F2 · derivative.exercise_date: Represents restricted stock units ("RSUs") granted to the Reporting Person. Each RSU represented a contingent right to receive one share of Issuer Common Stock upon vesting of the RSU. F3 · derivative.exercise_date: Pursuant to the Merger Agreement, at the Effective Time, each RSU that was outstanding as of immediately prior to the Effective Time was cancelled and converted into the right to receive a cash payment (without interest and subject to any applicable tax withholding) equal to (A) the Offer Price, multiplied by (B) the number of shares of Issuer Common Stock subject to such RSU. F2 · derivative.expiration_date: Represents restricted stock units ("RSUs") granted to the Reporting Person. Each RSU represented a contingent right to receive one share of Issuer Common Stock upon vesting of the RSU. F3 · derivative.expiration_date: Pursuant to the Merger Agreement, at the Effective Time, each RSU that was outstanding as of immediately prior to the Effective Time was cancelled and converted into the right to receive a cash payment (without interest and subject to any applicable tax withholding) equal to (A) the Offer Price, multiplied by (B) the number of shares of Issuer Common Stock subject to such RSU. Read SEC document |
| March 12, 2024 Filed Mar 12, 2024 10:06 UTC | Science 37 Holdings, Inc. SNCE · Entity 15235 | OtherCommon Stock | 2,050 | $5.75 | $11,787.50 |
DisclosureSEC source: 0001819113-24-000017 · wk-form4_1710252389.xml · nonDerivative · entry 1 Rollins Emily · CIK 0001847014 · Former Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · price: This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the "Merger Agreement"), dated as of January 28, 2024, among the Issuer, eMed, LLC, a Delaware limited liability company ("Parent"), and Marlin Merger Sub Corporation, a Delaware corporation and a wholly owned subsidiary of Parent ("Merger Sub"), pursuant to which Merger Sub completed a tender offer for shares of common stock of the Issuer ("Issuer Common Stock") at a purchase price of $5.75 per share, without interest and subject to applicable withholding taxes (the "Offer Price"). After completion of the tender offer, Merger Sub merged with and into the Issuer, effective as of March 12, 2024 (such date and time of such merger, the "Effective Time"). These shares of Issuer Common Stock were tendered for purchase pursuant to the tender offer. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:37 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 1,000 | $80.88 | $80,880.00 |
DisclosureSEC source: 0000950170-24-026086 · ownership.xml · nonDerivative · entry 1 Rollins Emily · CIK 0001847014 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,493 F1 · balance_after: Shares held following the reported transaction include 2,952 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| February 27, 2024 Filed Mar 1, 2024 00:07 UTC | Xometry, Inc. XMTR · Entity 1915 | GrantClass A Common Stock | 5,416 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-002000 · primarydocument.xml · nonDerivative · entry 1 Rollins Emily · CIK 0001847014 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,186 F1 · shares: Represents a restricted stock unit ("RSU") grant. All of the shares underlying the RSUs will vest on January 1, 2025, subject to the Reporting Person's continuous service. F2 · price: Each RSU represents a contingent right to receive one share of the Class A Common Stock of the Issuer. Read SEC document |
| February 06, 2024 Filed Feb 8, 2024 21:48 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GrantClass A Common Stock | 2,952 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-012853 · ownership.xml · nonDerivative · entry 1 Rollins Emily · CIK 0001847014 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,493 F1 · acquired: Award represents a total of 2,952 restricted stock units granted under the terms of the Issuer's 2020 Stock Plan. Each unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon vesting, which will occur on the earlier of (i) the first anniversary of the date of grant or (ii) the date immediately preceding the date of Issuer's 2025 annual meeting of stockholders, provided that, in either case, the Reporting Person continues to serve as a member of the Issuer's board of directors on such date. F2 · balance_after: Shares held following the reported transactions include 2,952 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| January 26, 2024 Filed Jan 29, 2024 22:31 UTC | Xometry, Inc. XMTR · Entity 1915 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,000 | $0.00 Strike: $12.32 | $0.00 |
DisclosureSEC source: 0001562180-24-000774 · primarydocument.xml · derivative · entry 3 Rollins Emily · CIK 0001847014 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 1,000 shares Expires 2031-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted and amended by the reporting person at least 90 days prior to the trading date. F4 · derivative.exercise_date: Shares vest in 48 monthly installments beginning on April 2, 2021, subject to the Reporting Person's continuous service. Read SEC document |
| January 26, 2024 Filed Jan 29, 2024 22:31 UTC | Xometry, Inc. XMTR · Entity 1915 | SaleClass A Common Stock | 1,000 | $32.39 | $32,393.80 |
DisclosureSEC source: 0001562180-24-000774 · primarydocument.xml · nonDerivative · entry 2 Rollins Emily · CIK 0001847014 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 10,770 F2 · kind: Represents shares sold in a transaction that was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.10 to $32.72, inclusive. The reporting person undertakes to provide to Xometry, Inc., any security holder of Xometry, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this price range. Read SEC document |
| January 26, 2024 Filed Jan 29, 2024 22:31 UTC | Xometry, Inc. XMTR · Entity 1915 | Exercise / conversionClass A Common Stock | 1,000 | $12.32 | $12,320.00 |
DisclosureSEC source: 0001562180-24-000774 · primarydocument.xml · nonDerivative · entry 1 Rollins Emily · CIK 0001847014 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,770 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted and amended by the reporting person at least 90 days prior to the trading date. Read SEC document |
| December 29, 2023 Filed Jan 2, 2024 21:52 UTC | Xometry, Inc. XMTR · Entity 1915 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,000 | $0.00 Strike: $12.32 | $0.00 |
DisclosureSEC source: 0001562180-24-000025 · primarydocument.xml · derivative · entry 4 Rollins Emily · CIK 0001847014 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 1,000 shares Expires 2031-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted and amended by the reporting person at least 90 days prior to the trading date. F5 · derivative.exercise_date: Shares vest in 48 monthly installments beginning on April 2, 2021, subject to the Reporting Person's continuous service. Read SEC document |
| December 29, 2023 Filed Jan 2, 2024 21:52 UTC | Xometry, Inc. XMTR · Entity 1915 | SaleClass A Common Stock | 180 | $37.95 | $6,830.86 |
DisclosureSEC source: 0001562180-24-000025 · primarydocument.xml · nonDerivative · entry 3 Rollins Emily · CIK 0001847014 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 10,770 F2 · kind: Represents shares sold in a transaction that was effected automatically pursuant to a Rule 10b5-1 trading plan adopted and amended by the reporting person at least 90 days prior to the trading date. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.64 to $38.235. Read SEC document |
| December 29, 2023 Filed Jan 2, 2024 21:52 UTC | Xometry, Inc. XMTR · Entity 1915 | SaleClass A Common Stock | 820 | $36.59 | $30,002.82 |
DisclosureSEC source: 0001562180-24-000025 · primarydocument.xml · nonDerivative · entry 2 Rollins Emily · CIK 0001847014 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 10,950 F2 · kind: Represents shares sold in a transaction that was effected automatically pursuant to a Rule 10b5-1 trading plan adopted and amended by the reporting person at least 90 days prior to the trading date. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.33 to $36.96, inclusive. The reporting person undertakes to provide to Xometry, Inc., any security holder of Xometry, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price in the ranges set forth in footnotes (3) and (4) to this Form 4. Read SEC document |
| December 29, 2023 Filed Jan 2, 2024 21:52 UTC | Xometry, Inc. XMTR · Entity 1915 | Exercise / conversionClass A Common Stock | 1,000 | $12.32 | $12,320.00 |
DisclosureSEC source: 0001562180-24-000025 · primarydocument.xml · nonDerivative · entry 1 Rollins Emily · CIK 0001847014 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,770 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted and amended by the reporting person at least 90 days prior to the trading date. Read SEC document |
| December 01, 2023 Filed Dec 5, 2023 21:07 UTC | Xometry, Inc. XMTR · Entity 1915 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,000 | $0.00 Strike: $12.32 | $0.00 |
DisclosureSEC source: 0001562180-23-008100 · primarydocument.xml · derivative · entry 4 Rollins Emily · CIK 0001847014 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 1,000 shares Expires 2031-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted and amended by the reporting person at least 90 days prior to the trading date. F5 · derivative.exercise_date: Shares vest in 48 monthly installments beginning on April 2, 2021, subject to the Reporting Person's continuous service. Read SEC document |
| December 01, 2023 Filed Dec 5, 2023 21:07 UTC | Xometry, Inc. XMTR · Entity 1915 | SaleClass A Common Stock | 209 | $25.35 | $5,297.50 |
DisclosureSEC source: 0001562180-23-008100 · primarydocument.xml · nonDerivative · entry 3 Rollins Emily · CIK 0001847014 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 10,770 F2 · kind: Represents shares sold in a transaction that was effected automatically pursuant to a Rule 10b5-1 trading plan adopted and amended by the reporting person at least 90 days prior to the trading date. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.31 to $25.38. Read SEC document |
| December 01, 2023 Filed Dec 5, 2023 21:07 UTC | Xometry, Inc. XMTR · Entity 1915 | SaleClass A Common Stock | 791 | $24.96 | $19,740.59 |
DisclosureSEC source: 0001562180-23-008100 · primarydocument.xml · nonDerivative · entry 2 Rollins Emily · CIK 0001847014 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 10,979 F2 · kind: Represents shares sold in a transaction that was effected automatically pursuant to a Rule 10b5-1 trading plan adopted and amended by the reporting person at least 90 days prior to the trading date. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.30 to $25.27, inclusive. The reporting person undertakes to provide to Xometry, Inc., any security holder of Xometry, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price in the ranges set forth in footnotes (3) and (4) to this Form 4. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.